Teradyne is trading 4.1% down at $327.64, with no clear September 3, 2026 company-specific catalyst identified.
- Recent coverage cited an August 21 Baird downgrade, driven by valuation concerns and limited near-term catalysts.
- Teradyne announced new AI-focused UltraFLEXplus instruments on September 1.
- Neither development directly explains todayβs decline.